CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cowealth Medical China Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cowealth Medical China Co Ltd
1F, Guangqi Building, 456 Hongcao Road
Phone: +86 2160378999p:+86 2160378999 SHANGHAI, SHA  200233  China Ticker: 603122603122

Business Summary
Cowealth Medical China Co Ltd is a China-based company primarily engaged in the wholesale of medical equipment products. The Company’s business includes in-vitro diagnostic product consolidation, medical product distribution, and hospital empowerment services. The in-vitro diagnostic product consolidation business involves the wholesale of in-vitro diagnostic products, primarily including immunodiagnostics, biochemical diagnostics, clinical testing, point-of-care testing, molecular diagnostics, pathology, and microbiological testing. The medical product distribution business mainly engages in the wholesale and retail of equipment in the fields of radiotherapy, immunodiagnostics, and biochemical diagnostics. Hospital empowerment services primarily include the development of hospital department operation management software and the provision of guidance services for hospital department operation management. The Company primarily operates in the domestic market.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202512/31/2025Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board DunLi 69 4/1/2019 4/1/2019
Chief Financial Officer, General Manager, Director QiongzhiWang 68 6/25/2025 4/1/2019
Deputy General Manager, Director GuankaiZeng 48 4/1/2022 4/1/2019
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 161 (As of 12/31/2025)
Outstanding Shares: 398,052,633 (As of 12/31/2025)
Shareholders: 110,046
Stock Exchange: SHA
Fax Number: +86 2160378951


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 24, 2026